Literature DB >> 27146905

Dyssynchronization reduces dynamic obstruction without affecting systolic function in patients with hypertrophic obstructive cardiomyopathy: a pilot study.

Geneviève Giraldeau1,2, Nicolas Duchateau1,2,3, Bart Bijnens3,4, Luigi Gabrielli1,2,5, Diego Penela1,2, Reinder Evertz1,2, Lluis Mont1,2, Josep Brugada1,2, Antonio Berruezo1,2, Marta Sitges6,7.   

Abstract

Dyssynchrony from biventricular pacing (BiV) can reduce dynamic obstruction in hypertrophic obstructive cardiomyopathy (HOCM), but its consequences on the left ventricular (LV) systolic function are unknown. We evaluate changes in LV systolic function and assess the effectiveness of BiV in HOCM. Thirteen patients with HOCM (55 [33/75] years, five males) received a BiV device and underwent 2D transthoracic echocardiography before the implantation and at 12 months follow-up. Global longitudinal and radial strain, and the timing of segmental displacement curves were measured by commercial speckle-tracking software to assess LV systolic function and dyssynchrony. Peak gradient in the LV outflow tract (LVOT) significantly decreased from 80 [51/100] to 30 [5/66] mmHg (p = 0.005). LV global strain was preserved from baseline to follow-up: 35.1 [20.2/43.8] % vs. 32.6 [27.1/44.1] %, p = NS (radial), and -16.6 [-19.1/-14.4] % vs. -15.7 [-17.0/-14.2] %, p = NS (longitudinal). Dyssynchrony analysis using displacement curves showed inversion of wall motion timing with earlier displacement of the lateral wall at follow-up only in patients with reduction in LVOT gradient. BiV reduces LVOT obstruction in patients with HOCM when dyssynchronization of LV motion and inversion of the timing of LV wall activation are reached. Notably, this does not lead to further deterioration of LV systolic function at mid-term follow-up.

Entities:  

Keywords:  Biventricular pacing; Hypertrophic obstructive cardiomyopathy; Myocardial strain; Speckle-tracking

Mesh:

Year:  2016        PMID: 27146905     DOI: 10.1007/s10554-016-0903-3

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  35 in total

1.  Beneficial effects of biventricular pacing in a patient with hypertrophic cardiomyopathy and intraventricular conduction delay.

Authors:  C A Rinaldi; C A Bucknall; J S Gill
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

Review 2.  The role of echocardiographic deformation imaging in hypertrophic myopathies.

Authors:  Maja Cikes; George R Sutherland; Lisa J Anderson; Bart H Bijnens
Journal:  Nat Rev Cardiol       Date:  2010-05-11       Impact factor: 32.419

3.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

4.  Left ventricular dysfunction after long-term right ventricular apical pacing in the young.

Authors:  M V Tantengco; R L Thomas; P P Karpawich
Journal:  J Am Coll Cardiol       Date:  2001-06-15       Impact factor: 24.094

Review 5.  Adverse effects of long-term right ventricular apical pacing and identification of patients at risk of atrial fibrillation and heart failure.

Authors:  Antonio De Sisti; Manlio F Márquez; Joelci Tonet; Aimé Bonny; Robert Frank; Françoise Hidden-Lucet
Journal:  Pacing Clin Electrophysiol       Date:  2012-03-27       Impact factor: 1.976

6.  Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.

Authors:  Zoran B Popović; Deborah H Kwon; Micky Mishra; Adisai Buakhamsri; Neil L Greenberg; Maran Thamilarasan; Scott D Flamm; James D Thomas; Harry M Lever; Milind Y Desai
Journal:  J Am Soc Echocardiogr       Date:  2008-12       Impact factor: 5.251

7.  Two-dimensional strain analysis in patients with hypertrophic cardiomyopathy and normal systolic function: a 12-month follow-up study.

Authors:  Ioannis A Paraskevaidis; Dimitrios Farmakis; Costantinos Papadopoulos; Ignatios Ikonomidis; John Parissis; Aggelos Rigopoulos; Efstathios K Iliodromitis; Dimitrios Th Kremastinos
Journal:  Am Heart J       Date:  2009-09       Impact factor: 4.749

8.  Resynchronization or dyssynchronization--successful treatment with biventricular stimulation of a child with obstructive hypertrophic cardiomyopathy without dyssynchrony.

Authors:  Radoslaw Lenarczyk; Oskar Kowalski; Tomasz Kukulski; Jacek Kowalczyk; Zbigniew Kalarus
Journal:  J Cardiovasc Electrophysiol       Date:  2007-05

9.  Effects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic function.

Authors:  S Betocchi; M A Losi; F Piscione; M Boccalatte; L Pace; P Golino; P Perrone-Filardi; C Briguori; F Franculli; C Pappone; M Salvatore; M Chiariello
Journal:  Am J Cardiol       Date:  1996-03-01       Impact factor: 2.778

10.  Initial experience of a cohort of patients with hypertrophic cardiomyopathy undergoing biventricular pacing.

Authors:  Christopher A Rinaldi; Senthil Kirubakaran; Clifford A Bucknall; Julian Bostock; Jaswinder S Gill
Journal:  Indian Pacing Electrophysiol J       Date:  2011-02-08
View more
  2 in total

Review 1.  Cardiac pacing in patients with hypertrophic obstructive cardiomyopathy.

Authors:  José Maria Tolosana; Emilce Trucco
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

Review 2.  Update on hypertrophic cardiomyopathy and a guide to the guidelines.

Authors:  Srijita Sen-Chowdhry; Daniel Jacoby; James C Moon; William J McKenna
Journal:  Nat Rev Cardiol       Date:  2016-09-29       Impact factor: 32.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.